A91 Partners.
The mid-market compounder built by ex-Sequoia MDs: $1.57bn across three funds, three listings in 24 months (Digit, Aye Finance, SEDEMAC at 3.6x), and a book that looks more like growth PE than venture: profitable, traditional, pre-IPO.
GW GP Score
A91 runs the least venture-shaped book in the cohort and that is the point: $10-50M cheques into profitable consumer, financial-services and manufacturing companies (SEDEMAC mechatronics, Spacewood furniture, Aye Finance NBFC) that list on Indian exchanges at honest multiples. Three IPOs in 24 months and Atomberg queued for FY27 make its realisation cadence the most predictable in the cohort. The 2025-26 wrinkle: first US AI cheque (Deccan AI) and late-stage SaaS (MoEngage), a deliberate widening from the India-consumer core.
Re-up candidate: the realised-cash evidence is doing more work than the brand story.
Portfolio quality depends on a narrow theme; the right comp is concentration risk, not headline unicorn count.
No named analyst override yet; current view is generated from the scored dossier and should be refreshed when the next primary source lands.
Atomberg DRHP (~Jul 2026 target) and FY27 listing: the next conveyor event.
River EV round (~$80M at ~$200M, Feb 2026 talks): unconfirmed as of Jul 2026.
Mid-market multiples cap the upside: a 3-4x realisation engine underperforms badly if Indian smallcap IPO appetite closes.
Computed from current dossier sources; analyst override pending.
The most predictable realisation machine in Indian growth investing: mid-market PE discipline applied to a venture-adjacent book. Capped upside, low variance, stable bench.
Three fresh listings + Atomberg/GIVA/Blue Tokai queue; profitable but rarely spectacular
Steadiest IPO conveyor in the cohort; honest 3-4x OFS multiples
Consumer/manufacturing core is defensive; AI exposure is one cheque old
$665M in ~13 months, though under the $750M ambition
Founding trio intact since 2018; no departures found
Portfolio quality 25% · Exit realisation 30% · Sector positioning 15% · Capital velocity 15% · Franchise stability 15%: see the full GP Score methodology · compare this firm →
Positive catalysts and/or re-up evidence exceed the visible risks, but the score should move only after the named proof lands.
Go Digit liquidity clears with credible OFS/block-sale evidence.
River EV round (~$80M at ~$200M, Feb 2026 talks): unconfirmed as of Jul 2026.
Atomberg DRHP (~Jul 2026 target) and FY27 listing: the next conveyor event.
A91 is the low-beta allocation in an Indian venture portfolio: three listings in 24 months, honest multiples, no DPI theatrics. Pair it with a power-law seed manager rather than comparing them: it is a different asset.
Mid-market multiples cap the upside: a 3-4x realisation engine underperforms badly if Indian smallcap IPO appetite closes.
Atomberg DRHP (~Jul 2026 target) and FY27 listing: the next conveyor event.
Coverage initiated: inaugural GW GP Score.
Catalyst exposure · latest source pressure
Recent public evidence mapped to this GP. Read this before reading the position table: it is where the score can move next.
Keep the file warm; current events cut both ways or are not yet material enough to move score.
Attribution1 positive catalyst(s), 0 pressure catalyst(s); top driver: India PE-VC value down 5% YoY in H1 CY2026.
The broad private-capital backdrop is selective rather than euphoric; fundraising and mark support now need firm-specific proof.
Score pressureRaises the bar for weak-DPI managers and stale flagship vehicles; rewards funds with fresh closes or visible exits.
Separate broad PE-VC softness from venture AI strength before changing sector-positioning scores.
The funds
~$1.57bn raised across 3 funds across 3 tracked vehicles.
| Vehicle | Vintage | Size | Stage | Note |
|---|---|---|---|---|
| Fund III (GIFT Trust III) | 2025Recovery / IPO window | $665M | Growth | Closed Apr 2025 in ~13 months vs $750M initial ambition; IFC weighed up to $65M |
| Fund II | 2021Peak frenzy | $550M | Growth | — |
| Fund I | 2019Expansion | $351M | Growth | Maiden fund: Digit, SEDEMAC, Atomberg vintage |
Closest booksIndia Quotient (2 shared) · Kenro Capital (1 shared) · Creaegis (1 shared)computed · E
Fund analytics · LP underwriting screen
Computed from the public dossier: vehicle cadence, realised exits, mark drift, concentration and franchise stability. All computed signals are GW estimates.
Latest vehicle closed inside the current exit/repricing window.
Next liquidityGo Digit · Aye Finance · Atomberg · GIVA · MoEngage
2 visible exit events since Jul 2024.
Latest vehicle closed inside the current exit/repricing window.
7 up / 4 flat / 0 down tracked signals.
No senior departure flagged in key people.
7 up / 4 flat / 0 down
2 events since Jul 2024
Largest tracked active exposure
Higher spread = less balanced franchise
Exit-led repricing; entry discipline decisive
Cycle-top entry marks; the vintage still being digested
Rational growth vintages
Listed May 2024; entered at ~$870M post-money vs ~$3bn IPO: ~3-3.5x paper (E)
Listed Feb 2026, +29.5% post-listing; held >9% at IPO
DRHP targeted ~Jul 2026, ₹1,500-2,000 Cr, FY27 listing; A91 diluting below 20%
9.58% pre-Series C; ₹530 Cr Creaegis round at $465M (Jun 2025)
Entered $100M Goldman-led round Nov 2025
At least one cited source is dated 2026.
4 visible events tracked.
12 representative positions tracked.
No departure signal structured.
Fund-level DPI/TVPI is usually not public; proxy remains estimated.
Peer median 2 · +0
Peer median 2 · +3
Peer median 74 · +4
Peer median 62 · +3
Peer median 0 · +0
Diligence agenda · how this view can change
The live research question, the proof required, and the source standard. This prevents a GP score from becoming a stale label.
The dossier is current and has near-term liquidity or fund events that can change the view quickly.
Current · At least one cited source is dated 2026.
Atomberg DRHP (~Jul 2026 target) and FY27 listing: the next conveyor event.
Refresh after each filing, listing, OFS, first close, final close or partner announcement.
River EV round (~$80M at ~$200M, Feb 2026 talks): unconfirmed as of Jul 2026.
Go Digit: next public-market or secondary print
Evidence quality · source file health
How hard the public record is beneath this view: source mix, freshness, low-confidence fields and the next source action.
No major evidence gap flagged.
6 total sources · 17% primary
At least one cited source is dated 2026.
Inc42: SEDEMAC IPO: A91 nets ₹325 Cr (Mar 2026)
Maintain monthly source check; escalate on fund close, DRHP, OFS, block sale or senior-partner change.
Source tiering follows Gravitywell policy: primary = filing/regulator/company disclosure, secondary = reputable media or research, E = Gravitywell estimate. Evidence score is a GW control metric, not an external rating.
The position book
~39 companies across 62 rounds: deliberately concentrated. 12 tracked below.
| Company | Sector | Entered | Entry stage | Status | 12-mo signal | Latest read |
|---|---|---|---|---|---|---|
| Go Digit | Fintech | 2020 | Series C | Public | → | Listed May 2024; entered at ~$870M post-money vs ~$3bn IPO: ~3-3.5x paper (E) |
| SEDEMAC | Logistics & Infra | 2019 | Growth | Public | ▲ | Listed Mar 2026 (+13.5%); ₹325 Cr OFS at 3.6x; ₹760 Cr still held |
| Aye Finance | Fintech | 2019 | Growth | Public | ▲ | Listed Feb 2026, +29.5% post-listing; held >9% at IPO |
| Atomberg | Consumer & Commerce | 2019 | Growth | Soonicorn | ▲ | DRHP targeted ~Jul 2026, ₹1,500-2,000 Cr, FY27 listing; A91 diluting below 20% |
| GIVA | Consumer & Commerce | 2021 | Growth | Soonicorn | ▲ | 9.58% pre-Series C; ₹530 Cr Creaegis round at $465M (Jun 2025) |
| Blue Tokai | Consumer & Commerce | 2021 | Series B | Private | ▲ | Largest external holder at 23.5%; ₹325 Cr FY25 revenue, +50% YoY |
| MoEngage | SaaS & Dev Tools | 2025 | Series F | Soonicorn | ▲ | Entered $100M Goldman-led round Nov 2025 |
| Deccan AI | AI | 2026 | Series A | Private | ▲ | Led $25M: first US-domiciled AI bet (Mountain View/Hyderabad) |
| Spacewood | Consumer & Commerce | 2025 | Growth | Private | · | ₹300 Cr at ~₹1,200 Cr valuation: classic A91 profitable-traditional deal |
| Sugar Cosmetics | Consumer & Commerce | 2019 | Growth | Private | → | BPC brand |
| Exotel | SaaS & Dev Tools | 2020 | Growth | Private | → | Cloud communications: co-held with Blume |
| Paper Boat | Consumer & Commerce | 2019 | Growth | Private | → | Hector Beverages |
Representative tracked positions reconstructed from public disclosures: not the full book. 12-mo signal is a GW estimate of mark direction from round/exit prints (E). Ownership stakes are not shown: not reliably public.
Sector exposure · where the book leans
Share of the tracked active book by normalized sector (GW estimate): read against our sector dossiers for crowding.
New cheques · 2025-26
The 2025-26 cheques tell a widening story: the core remains profitable Indian consumer and manufacturing (Spacewood, Blue Tokai), but MoEngage and Deccan AI mark the first serious moves into late-stage SaaS and US-domiciled AI. River EV talks (~$80M at ~$200M, Feb 2026) remain unconfirmed.
With Anicut, Verlinvest, 12 Flags
SAP transformation consultancy
GenAI data infra; with Susquehanna, Prosus
60% primary / 40% secondary with Goldman Sachs
Realisation · are LPs getting paid?
Three listings in 24 months with a fourth (Atomberg) queued: the steadiest IPO conveyor in the cohort. Multiples are mid-market honest (3-4x), not venture heroic; the model is repeatable precisely because it never depended on 40x outcomes.
Pure-OFS ₹1,087 Cr listing at +13.5%; A91 the biggest seller: ₹325 Cr at 3.6x, retaining ₹760 Cr.
₹1,010 Cr issue at ₹129; +29.5% post-listing. A91 held >9%; OFS participation not confirmed.
₹2,615 Cr issue; A91 pre-IPO holder at 3.36%; ~3-3.5x paper from the 2020 entry (E).
Partial stake sale in the $86M Temasek/Steadview round; further 2026 secondary to move below 20% pre-IPO.
Digit, Aye Finance, SEDEMAC: Atomberg next (FY27)
₹325 Cr cash, ₹760 Cr still on the book
Slightly under the $750M headline ambition; IFC weighed $65M total
No public fund-level DPI/TVPI
No fund-level numbers public. GW read: the listing cadence plus honest OFS multiples suggests dependable, PE-like distributions rather than power-law returns, a different product than the rest of the cohort, and LPs (IFC among them) are buying exactly that. E.
What they're doing
Mid-market PE in venture clothing: $10-50M into ~15 profitable companies per fund, primary + secondary structures, GIFT City vehicle.
Pre-IPO discipline: position, dilute below promoter thresholds, sell measured OFS tranches, retain upside (SEDEMAC template).
Widen the aperture carefully: first US AI cheque (Deccan AI) and late-stage SaaS (MoEngage) without abandoning the profitable-traditional core.
Concentration as risk control: ~39 positions across seven years.
What can break
Mid-market multiples cap the upside: a 3-4x realisation engine underperforms badly if Indian smallcap IPO appetite closes.
Consumer-brand concentration (Atomberg, GIVA, Blue Tokai, Sugar) rides the same discretionary-spend cycle.
The AI/SaaS widening is unproven territory for a team whose edge is Indian pre-IPO mechanics.
Atomberg DRHP (~Jul 2026 target) and FY27 listing: the next conveyor event.
River EV round (~$80M at ~$200M, Feb 2026 talks): unconfirmed as of Jul 2026.
Whether A91 sold in the Aye Finance OFS: unconfirmed.
Point-in-time discipline: these are the open items we could not verify at the current vintage. They get resolved: confirmed, corrected or dropped, at the next monthly refresh, never silently.
The takes · one screen, three readers
A91 is the low-beta allocation in an Indian venture portfolio: three listings in 24 months, honest multiples, no DPI theatrics. Pair it with a power-law seed manager rather than comparing them: it is a different asset.
A91 wins profitable-company deals by offering founders IPO mechanics, not markup theatre. Competing for a consumer or manufacturing Series C? Their pre-IPO playbook is the pitch to beat.
The A91 book is a screen for IPO-ready mid-caps: Atomberg (FY27), GIVA and Blue Tokai are the queue. Their entry into a category (Spacewood/furniture) flags private comps repricing 12-24 months before bankers arrive.
Sourcing. Every figure is sourced and dated. We tier provenance: Primary (official, regulatory, exchange or company filings), Secondary (tier-1 industry research and reputable media), and GW estimate (our own reconstruction or opinion, labelled, never presented as external fact). We prefer primary where it exists, reconcile divergent prints to cited ranges, and hold every number point-in-time: dated, and never silently restated; revisions publish as dated changes.
Fact vs opinion. Facts vs opinion: market sizes, official prints, prices, named deals and agency ratings are sourced facts (Primary/Secondary). Scores, grades, purity weights, scenario paths and indicative sparkline points are Gravitywell's analytical opinion (GW estimate): labelled, not presented as external data.
GW GP Scores are research opinions, not investment advice, not a solicitation, and not an assessment under any SEBI regulation. Dossiers are compiled from public sources believed reliable; firms named did not participate and figures marked E are Gravitywell estimates. Point-in-time: dated to the vintage shown and never silently restated.